Because hepatocytes are the main source for A1AT, polymers of A1AT can promote liver damage with a variable clinical presentation, from neonatal hepatitis to liver cirrhosis and hepatocellular carcinoma in adults. This evidence concerns the gene SERPINA1 and cirrhosis of liver.